A registry study across 14 Japanese clinics analyzed 179 cases of post-COVID-19 vaccination syndrome (PCVS) and identified ...

GRAND RAPIDS, Mich. (WOOD) — A new study could explain the impact of COVID-19 on the brain and why some people deal with lingering symptoms even years later. “When you look at the first round of COVID ...

The 2024-2025 mRNA COVID-19 vaccine provided moderate protection against severe outcomes, including hospitalizations and ED visits.

In this photo illustration, Ruth Jones, immunization nurse, holds a Pfizer-BioNTech COVID-19 vaccine at Borinquen Health Care Center on May 29, 2025, in Miami. Health Secretary Robert F. Kennedy Jr.

CHICAGO, April 24 (Reuters) - Thousands of Americans campaigning for the Novavax (NVAX.O), opens new tab COVID-19 booster got some good news this week: the FDA signaled it might still win approval ...

Researchers have discovered how to identify immunosuppressed people least likely to have COVID-19 antibodies, and suggested their findings might inform bespoke booster schedules for this population.

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases. By ...